FDA
-
-
-
-
-
-
-
ENDRA Life Sciences begins staking HYPE digital assets with partners
-
-
-
-
-
-
-
ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard
-
-
-
-
-
-
-
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
-
-
-
-
-
-
-
ENDRA Life Sciences (NDRA) Announces Reverse Stock Split
-
-
-
-
-
-
-
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
ENDRA Life Sciences (NDRA) Submits De Novo Request for TAEUS
-
-
-
-
-
-
-
ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

